Genocea Biosciences, Inc. (NASDAQ:GNCA) represented a move of -4.39 percent or $0.05 per share and closed its previous day trading session at $0.98. 899239 Shares were traded in the last trading session with an Average Volume of 921.87 Million Shares. The stock currently has a Market Capitalization of 84.72 Million.
Genocea Biosciences, Inc. is involved in developing vaccines. The company’s proprietary discovery platform consists of AnTigen Lead Acquisition System which designs vaccines that stimulate T cell immunity. Its product portfolio which are in different clinical trials consist of GEN-003, HSV-2 infections, GEN-004 and HSV-2 prophylaxis and malaria. Genocea Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
The stock traded between $0.790 and $7.290 over 1-Year time period showing its price to sales ratio of 0. Genocea Biosciences, Inc. (NASDAQ:GNCA) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-5.81 and 200-Day Simple Moving Average of $-70.56. Its Price to Free Cash Flow is 0 and Price to Book of 7.54.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Genocea Biosciences, Inc. (NASDAQ:GNCA) reported its Actual EPS of $-0.59/share. The analysts offering Earnings Estimates for the company were believing that Genocea Biosciences, Inc. could bring EPS of $-0.53/share. The difference between Actual EPS and Estimated EPS was -0.06 Percent. Thus showing an Earnings Surprise of -11.3 Percent.
Rayonier Advanced Materials Inc. (NYSE:RYAM)
In the last trading session, Rayonier Advanced Materials Inc. (NYSE:RYAM) added its value by 2.32% closing at the price of $18.51. The stock currently has market capitalization of 965.11 Million, with average volume of 708.98 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Rayonier Advanced Materials Inc. (NYSE:RYAM) is showing beta of 3.32. This particular value of beta suggests that Rayonier Advanced Materials Inc. (NYSE:RYAM) has historically moved 332% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Rayonier Advanced Materials Inc. (NYSE:RYAM) is at $0.54.
The stock currently has RSI of 48.5. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Rayonier Advanced Materials Inc. operates as a global supplier of cellulose specialties products, a natural polymer for the chemical industry. Its products include cellulose specialties primarily used in dissolving chemical applications; commodity viscose used in the manufacture of textiles for clothing and other fabrics, and in non-woven applications; absorbent materials comprising fibers for absorbent hygiene products and other products. Rayonier’s products are used in a wide range of industrial and consumer products such as filters, cosmetics and pharmaceuticals. The Company’s production facilities are located primarily in Jesup, Georgia, and Fernandina Beach, Florida. Rayonier Advanced Materials Inc. is headquartered in Jacksonville, Florida.
Rayonier Advanced Materials Inc. (NYSE:RYAM) topped its 52-week high price of $20.99 on 12/28/17 and 52-Week Low Price of $11.88 on 05/02/17. The Stock currently has P/E (price to earnings ttm) of 34.41 and Weekly volatility of 3.75% and monthly volatility of 3.19% respectively.